Cycle Pharmaceuticals Limited (Cycle) is pleased to announce the launch of JAVYGTOR™ (sapropterin dihydrochloride) Tablets for Oral Use and Powder for Oral Solution, as a treatment option for patients with Phenylketonuria (PKU), approved by the US Food and Drug Administration (FDA).
This site is intended for US consumers